ClinicalTrials.gov
public full text
Public Domain
OTIS Vedolizumab Pregnancy Exposure Registry
The purpose of this study is to assess the prevalence of major structural birth defects in infants of female participants with ulcerative colitis (UC) or Crohn's disease (CD) exposed to vedolizumab during pregnancy, compared to participants with UC or CD exposed to other biologic agents.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Detection of placenta accreta spectrum and prediction of adverse perinatal outcomes in pregnant women with placenta previa using ultrasonography and magnetic resonance imaging: A retrospective cohort study#240433
- Pilot Study: Identification of a Multi-omic Predictive Signature for Preterm Birth in Obese African American Women#1096007
- Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease#1152884
- Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)#146478
- Prenatal Substance Exposure and Multilevel Predictors of Child Protection System Reporting.#263110
Record · ID 1114552
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive